Product Loss and Waste in HOF: The Real Cost per ml

Every HOF professional knows the scene: the plan called for 1.5 ml, the syringe holds 1 ml, and half a syringe is left over that cannot be used on another patient. The loss looks small, but it repeats every week. Add the product that expires in the cabinet and the material spoiled by improper storage, and the ml you pay for ends up costing much more than the invoice says.

This guide shows how to measure loss, how it enters the real cost per ml and the price, and how to reduce it without creating any clinical risk. The numbers are hypothetical and only illustrate the math, without indicating market values. The indication, volume and technique are decisions for the licensed professional, after assessment.

Why the ml you buy is not the ml you charge for

The purchase price per ml is the starting point, but what matters for margin is the price per usable ml: what was actually applied and charged. The gap comes from four sources.

Each has a different fix, and mixing the four up leads to the wrong measures. For example, buying less to avoid expiry can increase stockouts at the worst moment, and buying larger syringes to save per ml can increase leftovers.

The formula for the real cost per ml

Over a period (a month or a quarter), do the following:

1. Add up everything you spent on the product (purchases in the period, adjusted for opening and closing stock).
2. Add up the ml actually applied and charged.
3. Divide the first figure by the second.

The result is the cost per usable ml. Compare it with the purchase price per ml: the percentage difference is your loss rate.

Hypothetical example

Suppose a fictional clinic spent R$ 18,000.00 on one type of product in a quarter and applied 90 ml in total.

If the selling price was calculated from R$ 170.00 per ml, the clinic believed its margin was higher than it really is. Each ml charged carries R$ 30.00 of loss that nobody was paying for. Across 90 ml, the hidden loss is R$ 2,700.00 for the quarter (hypothetical example).

How loss enters the price

There are three ways to handle it, and the most honest is a combination:

1. Use the cost per usable ml (not the invoice cost) as the basis for the price. This is the most accurate method. See pricing per ml and cost of disposable supplies per patient.
2. Reduce the loss through purchase and treatment-plan planning, which improves margin without raising prices.
3. Review your product size policy by plan type, so the typical leftover shrinks.

Do not pass the loss on to the patient in an opaque way, and do not change the clinical indication to reduce it. If the patient's plan is 1.5 ml, the plan is 1.5 ml. The cost of the leftover is a business cost, not a reason to indicate 2 ml. For the concept of contribution margin, see the glossary entry and the page profit margin in HOF.

Measuring loss in practice

You do not need a sophisticated system. A spreadsheet with four columns per product does the job:

The most important thing is to record the leftover at the moment it happens. Discovering the loss at the end of the month by looking at stock is guesswork. To organize the log, see injectable inventory in the HOF clinic and minimum stock and turnover.

How to reduce losses safely

Plan purchases around turnover

Buy based on what you actually use, not on the volume discount. A large lot with a short expiry date can cost more than a smaller one with a higher unit price. Compare the purchase cost with the cost of the expected loss.

Match packaging size to the plan

If most of your plans use fractions that leave a leftover, reviewing the available sizes can help. But the choice of size must never push you to indicate more volume than needed.

Schedule procedures smartly

When the schedule allows, grouping procedures that use the same product on one day reduces the number of packages opened. Caution: this only applies to products and situations where regulations and the manufacturer allow one package to be used for more than one patient, which generally is not the case with single-patient syringes. When in doubt, follow the package insert and health surveillance rules.

Control expiry with first-expired, first-out

Organize stock so that what expires first is used first. Label lot and expiry date, and check the shelf once a month.

Store according to the manufacturer

Products that require a cold chain or controlled temperature must be stored according to the package insert. Log the refrigerator temperature and keep dedicated equipment. See the glossary entries cold chain and expiration date.

Loss and the conversation with the patient

Loss should not come up as a sales argument. The patient does not need to hear "I'll lose money if you use less". They need to hear the plan, the reasoning behind the volume and an estimate by stages. When the recommended volume leaves a leftover, the professional still recommends what is clinically right.

One tool that helps make the plan concrete is the simulation: in Harmy, the volume in ml per area (from 0.5 to 5, in steps of 0.5) appears in the plan and the projection respects that volume. This lets you agree with the patient on what will be done before any product is opened, and reduces the chance of last-minute changes that create leftovers.

What to do about unavoidable losses

Some loss will always exist. Two sensible attitudes:

• Accept a percentage as part of the cost and build it into the price consistently.
• Log discards with the reason, to spot patterns. If the biggest loss comes from expiry, the problem is purchasing. If it comes from leftovers, the problem is the plan and the packaging. If it comes from damage, the problem is storage.

For defective or irregular products, record the issue and report it to the supplier and, when applicable, to the competent authorities. The glossary entry technovigilance explains the concept.

Effect on the month's results

Cutting the loss rate from 18% to 12% on a high-turnover product can affect margin more than a price increase, and it does not depend on the patient's decision. That is why loss control is one of the few margin adjustments entirely within the clinic's control. To see the effect overall, use the simple income statement for the HOF clinic and, for specific procedures, pricing collagen biostimulators and pricing skin boosters.